Colinz Laboratories Ltd.
| BSE: 531210 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE923C01011 |
| BSE 16:01 | 21 Sep | 5.80 |
-0.17 (-2.85%) |
OPEN
5.80 |
HIGH
5.80 |
LOW
5.80 |
| NSE 05:30 | 01 Jan | Colinz Laboratories Ltd |
| OPEN | 5.80 |
| PREVIOUS CLOSE | 5.97 |
| VOLUME | 1 |
| 52-Week high | 10.22 |
| 52-Week low | 5.80 |
| P/E | 20.00 |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 5.80 |
| Buy Qty | 99.00 |
| Sell Price | 6.59 |
| Sell Qty | 44.00 |
Colinz Laboratories Ltd. (COLINZLABS) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 503.65 | -3.75 | 564.90 | 315.20 | 120840.74 |
| Dr Reddy's Labs | 5139.20 | -3.52 | 5514.65 | 2497.60 | 85444.34 |
| Divi's Lab. | 3159.50 | -5.61 | 3388.00 | 1571.25 | 83868.93 |
| Cipla | 767.70 | -4.85 | 819.00 | 356.75 | 61903.49 |
| Biocon | 428.85 | -5.50 | 463.55 | 212.40 | 51462.00 |
| Lupin | 1039.50 | -4.24 | 1121.85 | 505.00 | 47104.94 |
| Aurobindo Pharma | 791.00 | -4.51 | 967.60 | 281.15 | 46344.69 |
| Torrent Pharma. | 2701.75 | -5.98 | 3040.00 | 1554.65 | 45719.01 |
| Cadila Health. | 394.60 | -3.56 | 422.80 | 212.70 | 40395.20 |
| Alkem Lab | 2860.05 | 0.11 | 3089.55 | 1850.00 | 34191.90 |
| Abbott India | 15900.00 | -3.71 | 18569.00 | 9722.00 | 33787.50 |
| Piramal Enterp. | 1273.65 | -5.67 | 1860.08 | 608.00 | 28727.18 |
| Glaxosmi. Pharma | 1671.35 | -1.62 | 1805.00 | 1046.40 | 28314.34 |
| Ipca Labs. | 2091.55 | -3.74 | 2235.80 | 844.20 | 26426.73 |
| Apollo Hospitals | 1825.00 | -0.21 | 1899.35 | 1047.45 | 25389.40 |
| Syngene Intl. | 561.00 | -1.19 | 594.75 | 201.65 | 22440.00 |
| Pfizer | 4827.10 | -3.19 | 5230.00 | 3069.40 | 22083.98 |
| Sanofi India | 8407.05 | -0.84 | 8999.00 | 5610.00 | 19361.44 |
| Alembic Pharma | 918.65 | -4.48 | 1128.00 | 436.10 | 18056.07 |
| Natco Pharma | 895.00 | 0.73 | 931.70 | 450.00 | 16293.47 |
Quick Links for Colinz Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
